Lotti R, Traverso C E, Murialdo U, Frau B, Calabria G A, Zingirian M
University Eye Clinic, Genova, Italy.
Ophthalmic Surg. 1995 Mar-Apr;26(2):127-9.
We analyzed the long-term success of argon laser trabeculoplasty (ALT) performed in 237 eyes of 175 patients diagnosed with primary open-angle glaucoma and followed for up to 11 years (maximum, 132 months) after treatment. The cumulative proportion of success, defined as the avoidance of glaucoma surgery or an intraocular pressure never exceeding 22 mm Hg, was calculated throughout follow up using the Kaplan-Meier life-table analysis. The success rates were: 78% at 1 year (n = 205), 71% at 3 years (n = 139), 61% at 5 years (n = 73), and 40% at 10.5 years (n = 19). Our data confirm previous reports of the high initial success rate of ALT, followed by a time-dependent decrease in its efficacy.
我们分析了对175例原发性开角型青光眼患者的237只眼睛进行氩激光小梁成形术(ALT)的长期疗效,这些患者在治疗后随访长达11年(最长132个月)。成功的累积比例定义为避免青光眼手术或眼压从未超过22 mmHg,在整个随访过程中使用Kaplan-Meier生命表分析进行计算。成功率分别为:1年时78%(n = 205),3年时71%(n = 139),5年时61%(n = 73),10.5年时40%(n = 19)。我们的数据证实了之前关于ALT初始成功率高,随后疗效随时间下降的报道。